Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypersensitivity to fluindione (Previscan). Positive skin patch tests].

E Frouin1, B Roth, A Grange

  • 1Service de Dermatologie, Hôpital Pasteur, Centre Hospitalier de Colmar.

Annales De Dermatologie Et De Venereologie
|February 1, 2006
PubMed
Summary

Fluindione (Previscan), a vitamin K antagonist, can cause severe hypersensitivity reactions, including rash, hepatitis, and kidney failure. Patch testing confirmed fluindione as the cause in a patient experiencing these symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can the Reboot coaching programme support critical care nurses in coping with stressful clinical events? A mixed-methods evaluation assessing resilience, burnout, depression and turnover intentions.

BMC health services research·2024
Same author

The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis: Biopsies prostatiques guidée par micro-échographie, quel bénéfice ? Une analyse lésion par lésion.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Prevalence of overweight, obesity, and early adiposity rebound in nursery school children in southeastern France.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
Same author

Study protocol for the online adaptation and evaluation of the 'Reboot' (Recovery-boosting) coaching programme, to prepare critical care nurses for, and aid recovery after, stressful clinical events.

Pilot and feasibility studies·2022
Same author

WITHDRAWN: The benefit of adopting Microultrasound in the prostate cancer imaging pathway : A lesion-by-lesion analysis

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

Surgical site infections: guidance for elective surgery during the SARS-CoV-2 pandemic - international recommendations and clinical experience.

The Journal of hospital infection·2021

Area of Science:

  • Pharmacology
  • Immunology
  • Dermatology

Background:

  • Fluindione (Previscan) is a widely prescribed oral anticoagulant in France, belonging to the vitamin K antagonist class.
  • While bleeding is a known complication, severe immunoallergic reactions are less common.
  • This report details a case of drug-induced hypersensitivity syndrome attributed to fluindione.

Observation:

  • A 75-year-old woman presented with a diffuse erythematous papular rash and facial edema 3 weeks after starting fluindione, allopurinol, and perindopril.
  • Laboratory findings revealed hyperleukocytosis, mixed hepatitis, and moderate renal failure, indicative of a drug reaction.
  • Eosinophilia, hepatic cytolysis with cholestasis, and acute renal failure were noted. Symptoms recurred upon fluindione reintroduction and resolved upon its withdrawal.

Findings:

Related Experiment Videos

  • The clinical presentation and laboratory results strongly suggested drug-induced hypersensitivity syndrome.
  • Positive skin patch tests confirmed fluindione as the causative agent, while allopurinol and perindopril were ruled out.
  • This case highlights the potential for severe immunoallergic reactions to fluindione, even when skin involvement is not the primary feature.

Implications:

  • Drug-induced hypersensitivity syndrome (DRESS) associated with fluindione, though rarely reported, necessitates clinical awareness.
  • Physicians should consider fluindione as a potential cause of DRESS, characterized by fever, hepatitis, and acute tubular interstitial nephritis.
  • Skin patch testing is a valuable diagnostic tool for identifying the specific drug responsible for hypersensitivity reactions.